v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses    
Research and development $ 15,703 $ 17,171
General and administrative 6,630 16,634
Total operating expenses 22,333 33,805
Operating loss (22,333) (33,805)
Other income and expense    
Other expense, net (1) (4)
Interest expense (17) (28)
Interest income 2,113 1,193
(Amortization of premium) accretion of discount on investments in U.S. Treasury securities, net 42 (12)
Total other income and expense 2,137 1,149
Loss from operations before income taxes (20,196) (32,656)
Net loss (20,196) (32,656)
Net unrealized gain (loss) on investments (330) 49
Total other comprehensive gain (loss) (330) 49
Comprehensive loss $ (20,526) $ (32,607)
Net loss per common share, basic $ (0.25) $ (0.99)
Net loss per common share, diluted $ (0.25) $ (0.99)
Weighted-average number of shares outstanding used in computation of net loss per common share, basic 81,183,812 33,113,991
Weighted-average number of shares outstanding used in computation of net loss per common share,diluted 81,183,812 33,113,991